title: Heart transplantation.
abstract: OBJECTIVE
  This paper briefly and subjectively reviews a number of the modest or tentative, but noteworthy, advances in heart transplantation that have been made during the past 18 months or so.
  
  
  RESULTS
  The advances reviewed concern the selection of recipients, the management of the heart transplantation waiting list, the management of donors, post-heart transplant monitoring of immunological status, the early diagnosis of rejection, the role of mammalian target of rapamycine inhibitors and induction agents, and the definition and grading of cardiac allograft vasculopathy.
  
  
  CONCLUSIONS
  The findings reviewed indicate progress in the clarification of issues that were in most cases already being investigated. Further studies will in general be needed before corresponding measures are adopted in clinical practice.
authors: Unidad de Insuficiência Cardíaca y Trasplante Cardíaco, Hospital Universitário A Coruña, La Coruña, Spain. marisa.crespo.leiro@sergas.es
authors: Maria G
authors: MG
authors: Crespo-Leiro
authors: Eduardo
authors: E
authors: Barge-Caballero
authors: Raquel
authors: R
authors: Marzoa-Rivas
authors: Maria J
authors: MJ
authors: Paniagua-Martin
mesh_terms: D046148:Donor Selection; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D016027:Heart Transplantation / Q000009:adverse effects / Q000639:trends; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015166:Monitoring, Immunologic; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution; D016896:Treatment Outcome; D014850:Waiting Lists
chemical_list: D007166:Immunosuppressive Agents